Evaluating the ready biodegradability of two poorly water-soluble substances: comparative approach of bioavailability improvement methods (BIMs)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1614-7499
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Evaluating the ready biodegradability of two poorly water-soluble substances: comparative approach of bioavailability improvement methods (BIMs) ; day:28 ; month:5 ; year:2016 ; pages:1-11
Environmental science and pollution research ; (28.5.2016), 1-11
- Creator
-
Sweetlove, Cyril
- Contributor
-
Chenèble, Jean-Charles
Barthel, Yves
Boualam, Marc
L’Haridon, Jacques
Thouand, Gérald
SpringerLink (Online service)
- DOI
-
10.1007/s11356-016-6899-3
- URN
-
urn:nbn:de:1111-20160530530
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sweetlove, Cyril
- Chenèble, Jean-Charles
- Barthel, Yves
- Boualam, Marc
- L’Haridon, Jacques
- Thouand, Gérald
- SpringerLink (Online service)
Other Objects (12)
Novel formulation principles for bioavailability enhancement of poorly water-soluble and poorly permeable drugs
Relevance of bioaccessibility for the oral bioavailability of poorly water-soluble drugs
Solubility/Bioavailability Enhancement and Modified Release Formulations of Poorly Water-Soluble Drugs
Improved oral bioavailability of poorly water-soluble vorinostat by self-microemulsifying drug delivery system
LIPOSOMES AS A LIPID-BASED FORMULATION TO INCREASE THE BIOAVAILABILITY OF POORLY WATER-SOLUBLE DRUG FENOFIBRATE
Nucleation Precursors of Poorly Water-Soluble Pharmaceutical Compounds
Development of Proliposomal and Liposomal Formulations with Poorly Water-soluble Drugs
Leveraging bile solubilization of poorly water-soluble drugs by rational polymer selection
Nanostructured lipid carrier formulation for delivering poorly water-soluble ITF3756 HDAC inhibitor
Non‐Aqueous Phospholipid Concentrates for Increasing the Bioavailability of Poorly Soluble Compounds
Water-Soluble Metalated Covalent Organic Nanobelts with Improved Bioavailability for Protein Transportation
Springs and parachutes - development and characterization of novel formulations for poorly water-soluble drugs
Novel formulation principles for bioavailability enhancement of poorly water-soluble and poorly permeable drugs
Relevance of bioaccessibility for the oral bioavailability of poorly water-soluble drugs
Solubility/Bioavailability Enhancement and Modified Release Formulations of Poorly Water-Soluble Drugs
Improved oral bioavailability of poorly water-soluble vorinostat by self-microemulsifying drug delivery system
LIPOSOMES AS A LIPID-BASED FORMULATION TO INCREASE THE BIOAVAILABILITY OF POORLY WATER-SOLUBLE DRUG FENOFIBRATE
Nucleation Precursors of Poorly Water-Soluble Pharmaceutical Compounds
Development of Proliposomal and Liposomal Formulations with Poorly Water-soluble Drugs
Leveraging bile solubilization of poorly water-soluble drugs by rational polymer selection
Nanostructured lipid carrier formulation for delivering poorly water-soluble ITF3756 HDAC inhibitor
Non‐Aqueous Phospholipid Concentrates for Increasing the Bioavailability of Poorly Soluble Compounds
Water-Soluble Metalated Covalent Organic Nanobelts with Improved Bioavailability for Protein Transportation
Springs and parachutes - development and characterization of novel formulations for poorly water-soluble drugs
Novel formulation principles for bioavailability enhancement of poorly water-soluble and poorly permeable drugs
Relevance of bioaccessibility for the oral bioavailability of poorly water-soluble drugs
Solubility/Bioavailability Enhancement and Modified Release Formulations of Poorly Water-Soluble Drugs
Improved oral bioavailability of poorly water-soluble vorinostat by self-microemulsifying drug delivery system
LIPOSOMES AS A LIPID-BASED FORMULATION TO INCREASE THE BIOAVAILABILITY OF POORLY WATER-SOLUBLE DRUG FENOFIBRATE
Nucleation Precursors of Poorly Water-Soluble Pharmaceutical Compounds
Development of Proliposomal and Liposomal Formulations with Poorly Water-soluble Drugs
Leveraging bile solubilization of poorly water-soluble drugs by rational polymer selection
Nanostructured lipid carrier formulation for delivering poorly water-soluble ITF3756 HDAC inhibitor
Non‐Aqueous Phospholipid Concentrates for Increasing the Bioavailability of Poorly Soluble Compounds
Water-Soluble Metalated Covalent Organic Nanobelts with Improved Bioavailability for Protein Transportation